NOVONIX
5 hedge funds and large institutions have $396K invested in NOVONIX in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.02% more ownership
Funds ownership: 0% → 0.02% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Scholtz & Company
Stamford,
Connecticut
|
+$284K |
| 2 |
FNT
First Nebraska Trust
Lincoln,
Nebraska
|
+$165K |
| 3 |
Rockefeller Capital Management
New York
|
+$17K |
| 4 |
Morgan Stanley
New York
|
+$825 |
| 5 |
Citigroup
New York
|
+$495 |
Top Sellers
NVX Hedge Fund Activity: Q1 2022 in Review
5 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in NOVONIX (NVX) for Q1 2022, worth a combined $396K.
Buyers outnumbered sellers: 5 funds opened new NVX positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Scholtz & Company, opening a new position worth an estimated $284K.
- 5 institutional investors held NOVONIX (NVX) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $396K of NOVONIX stock for Q1 2022.
- 5 funds opened new NOVONIX positions in Q1 2022 and 0 closed out, a net change of +5 holders.
- The largest NOVONIX buyer in Q1 2022 was Scholtz & Company, an estimated $284K added.
Based on aggregated 13F filings for Q1 2022.